With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.

A protein’s life is anything but simple. Discover how transcription, translation, folding, modification, and degradation work together to preserve proteome integrity.

Creative Biolabs is accelerating CAR‑T innovation, driving breakthroughs in solid tumor targeting. SHIRLEY, NY, UNITED ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

Gen 2 LED architecture delivers industry-leading efficacy, color quality, precision, and system-wide performance ...

By Hugo Francisco de Souza A new study shows that gut microbiome signatures, analyzed through advanced machine learning, can help identify individuals with more severe insulin resistance, offering ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion ...

US President Donald Trump has publicly declared that the world will know within 10 days whether Washington reaches a deal with Tehran or “takes things further".

Interview with Florian Wagenlehner, Director, Clinic of Urology, Pediatric Urology, and Andrology,Justus Liebig ...

Immunotherapy has transformed the treatment landscape for many cancers, yet its efficacy remains highly variable across tumor types and patient populations.

Russia's secret weapon – is 'strangling' enemy Starlink and GPS systems. This system jams across the Baltic and Scandinavia, ...